MetLife (NYSE:MET) Downgraded by StockNews.com to Hold

MetLife (NYSE:METGet Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday.

Several other brokerages have also recently weighed in on MET. Jefferies Financial Group upped their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. raised their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday. Barclays increased their price objective on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, Wells Fargo & Company boosted their target price on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.00.

View Our Latest Stock Analysis on MET

MetLife Stock Performance

NYSE:MET opened at $82.91 on Thursday. The company has a market capitalization of $57.41 billion, a P/E ratio of 16.72, a P/E/G ratio of 0.76 and a beta of 1.07. The business has a fifty day simple moving average of $82.85 and a two-hundred day simple moving average of $78.84. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife has a 1 year low of $64.61 and a 1 year high of $89.05.

Institutional Investors Weigh In On MetLife

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. MeadowBrook Investment Advisors LLC raised its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its stake in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new stake in MetLife during the 3rd quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC lifted its stake in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Company Profile

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.